Business Context and Reporting Period
This Form 8-K filing by Catalyst Biosciences, Inc. (ticker: CBIO) reports a corporate action effective February 10, 2017. The company, incorporated in Delaware, announced the implementation of a reverse stock split of its common stock.
Key Financial Metrics
This filing is a current report regarding a capital structure change and does not contain financial performance data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Reverse Stock Split: The Board of Directors executed a 1-for-15 reverse stock split, effective at 5:00 p.m. Eastern Time on February 10, 2017.
- Share Reclassification: Every 15 pre-split shares were automatically reclassified into 1 post-split share.
- Fractional Shares: No fractional shares were issued; holders entitled to fractions received cash payments in lieu thereof.
- Trading Adjustments: Trading on The Nasdaq Capital Market resumed on a split-adjusted basis on February 13, 2017. The ticker symbol remained "CBIO," but the CUSIP number changed to 14888D 208.
- Securities Adjustment: Exercise prices and share counts for outstanding convertible notes, stock options, warrants, and the 2015 Stock Incentive Plan were proportionately adjusted.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future performance, or specific risk factors beyond the mechanics of the stock split. The primary purpose of the split was to adjust the share count and price per share, likely to maintain compliance with Nasdaq listing requirements, though the filing text does not explicitly state this rationale.
Investor Verification Checklist
- Verify the new CUSIP number (14888D 208) for trading and settlement purposes.
- Confirm the adjusted number of shares held and any cash received for fractional shares.
- Review the adjusted exercise prices and share quantities for any held options, warrants, or convertible notes.
- Check the company's subsequent filings for updated financial statements reflecting the new share count.